This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2003 Apr;121(1):12-20.

doi: 10.1046/j.1365-2141.2003.04196.x.

Low-molecular-weight heparins: are they all the same?

Richard H White¹, Jeffrey S Ginsberg

Affiliations

PMID: 12670327
DOI: 10.1046/j.1365-2141.2003.04196.x

Review

Low-molecular-weight heparins: are they all the same?

Richard H White et al. Br J Haematol. 2003 Apr.

. 2003 Apr;121(1):12-20.

doi: 10.1046/j.1365-2141.2003.04196.x.

Authors

Richard H White¹, Jeffrey S Ginsberg

Affiliation

¹ Division of General Medicine, University of California-Davis, 4150 V Street, Sacramento, CA 95817, USA. rhwhite@ucdavis.edu

PMID: 12670327
DOI: 10.1046/j.1365-2141.2003.04196.x

No abstract available

PubMed Disclaimer

Similar articles

Low-molecular-weight heparins are essentially the same for treatment and prevention of venous thromboembolism.
Lopez LM. Lopez LM. Pharmacotherapy. 2001 Jun;21(6 Pt 2):56S-61S; discussion 71S-72S. doi: 10.1592/phco.21.8.56s.34596. Pharmacotherapy. 2001. PMID: 11401194 Review.
Thromboprophylaxis following caesarean section--a comparison of the antithrombotic properties of three low molecular weight heparins--dalteparin, enoxaparin and tinzaparin.
Ellison J, Thomson AJ, Conkie JA, McCall F, Walker D, Greer A. Ellison J, et al. Thromb Haemost. 2001 Dec;86(6):1374-8. Thromb Haemost. 2001. PMID: 11776302 Clinical Trial.
Selecting an agent for prophylaxis of venous thromboembolism.
Myers J. Myers J. Am J Health Syst Pharm. 2006 Dec 15;63(24):2448-50. doi: 10.2146/ajhp060231. Am J Health Syst Pharm. 2006. PMID: 17158692 No abstract available.
Selecting an anticoagulant for recurrent venous thromboembolism in cancer.
Goodin S. Goodin S. Am J Health Syst Pharm. 2005 Nov 15;62(22 Suppl 5):S10-3. doi: 10.2146/ajhp050431. Am J Health Syst Pharm. 2005. PMID: 16286363
Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolism.
Bauer KA, Eriksson BI, Lassen MR, Turpie AG. Bauer KA, et al. Curr Opin Pulm Med. 2002 Sep;8(5):398-404. doi: 10.1097/00063198-200209000-00010. Curr Opin Pulm Med. 2002. PMID: 12172443 Review.

See all similar articles

Cited by

A cost-effectiveness model comparing rivaroxaban and dabigatran etexilate with enoxaparin sodium as thromboprophylaxis after total hip and total knee replacement in the irish healthcare setting.
McCullagh L, Tilson L, Walsh C, Barry M. McCullagh L, et al. Pharmacoeconomics. 2009;27(10):829-46. doi: 10.2165/11313800-000000000-00000. Pharmacoeconomics. 2009. PMID: 19803538
Management of refractory venous thrombosis associated with malignancy using a supra-therapeutic enoxaparin regimen.
Cunningham MS, Gilmore R, O'Donnell D, O'Donnell JS. Cunningham MS, et al. Ir J Med Sci. 2009 Sep;178(3):339-41. doi: 10.1007/s11845-008-0200-9. Epub 2008 Aug 27. Ir J Med Sci. 2009. PMID: 18751756
Venous thromboembolism prophylaxis.
Laryea J, Champagne B. Laryea J, et al. Clin Colon Rectal Surg. 2013 Sep;26(3):153-9. doi: 10.1055/s-0033-1351130. Clin Colon Rectal Surg. 2013. PMID: 24436666 Free PMC article. Review.
The "Square Box": Therapeutic Equivalence as a Foundation of the WHO Model List of Essential Medicines.
Cappello B, Moja L, Figueras A, Magrini N. Cappello B, et al. Front Pharmacol. 2020 Sep 11;11:578000. doi: 10.3389/fphar.2020.578000. eCollection 2020. Front Pharmacol. 2020. PMID: 33071791 Free PMC article.
Low molecular weight heparin-induced thrombocytopenia management during hemodialysis and cardiac surgery: a case report and literature review.
Takada S, Suzuki S, Tamura T. Takada S, et al. JA Clin Rep. 2025 Mar 28;11(1):18. doi: 10.1186/s40981-025-00781-0. JA Clin Rep. 2025. PMID: 40153155 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- The Lens - Patent Citations Database